Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable routes.
Novel Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles offers high efficiency and substrate compatibility, enabling cost-effective API intermediate manufacturing.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction and scalable supply chain for high purity pharmaceutical intermediates globally.
Novel one-pot synthesis of 3-acyl pyridines using copper/TEMPO catalysis. Offers high atom economy and mild conditions for reliable API intermediate manufacturing.
Patent CN115353511A details a safe, multi-component synthesis for carbonyl-bridged biheterocycles using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN112979529B reveals a novel one-step synthesis for aromatic amine indole naphthoquinone derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for 1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109096139B discloses a novel metal-free method for preparing alpha-carbonyl amides using water as an oxygen source, offering significant cost and purity advantages for pharmaceutical intermediate manufacturing.
Patent CN113105402B details a metal-free route to 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel palladium-catalyzed carbonylation method for synthesizing carbonyl-bridged biheterocycles without toxic CO gas, offering safer pharmaceutical intermediate manufacturing.
Patent CN115353511A details a safe, one-pot synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering reliable pharmaceutical intermediate supply.
Patent CN116621792B enables efficient, water-based synthesis of N-butyl-benzisothiazolinone oxide with high yield, offering sustainable cost reduction and scalable supply for pharmaceutical intermediates.
Novel four-component one-step synthesis enables high-yield, scalable production of structurally diverse calixarene derivatives with superior recognition properties for industrial applications.
Patent CN104926811A enables efficient synthesis of 3-cyanoimidazo[1,2-a]pyridine intermediates using CuI catalysis, offering scalable, mild-condition routes for API manufacturing with enhanced supply chain reliability.
Patent CN119798149A introduces a three-step synthesis route eliminating hazardous reagents with enhanced purity control and scalable manufacturing for pharmaceutical intermediates.
Novel CuI-catalyzed method enables efficient production of high-purity imidazo[1,2-a]pyridine intermediates with improved scalability and reduced manufacturing complexity for pharmaceutical applications.
Patent CN106188044A details an iodine-catalyzed method for synthesizing thiolated imidazo[1,5-a]N-heterocycles without transition metals, enabling mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN102898327B enables eco-friendly DMAD production using dimethyl carbonate, ensuring supply chain reliability and significant cost savings for pharmaceutical intermediates.